Literature DB >> 14739535

The Fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer's disease.

Hanna Rosenmann1, Zeev Meiner, Esther Kahana, Zoja Aladjem, Gideon Friedman, Arie Ben-Yehuda, Tal Grenader, Eli Wertman, Oded Abramsky.   

Abstract

The Fas antigen is a cell surface receptor-mediating cell apoptosis. Recent studies have demonstrated that Fas-associated apoptosis is involved in the pathogenesis of Alzheimer's disease (AD). Moreover, the Fas gene is located on chromosome 10q24.1, a region of linkage to late-onset AD (LOAD). These two criteria, pathobiological and positional, make the Fas antigen an interesting candidate for an association with AD. We performed a case-control association study between the common A/G polymorphism at position -670 in the Fas gene (TNFSRF6) promoter and sporadic AD in Jews, investigating whether this locus acts as a risk factor or whether it has a modifying effect. An association has recently been detected by Feuk et al. in the Scottish population between this locus and the risk of early-onset AD (EOAD), but not of LOAD. In agreement with Feuk et al., we found no association between this locus and the risk of LOAD (n = 86). However, in our small sample of patients with EOAD (n = 19), no association was found either. No interactive effect was found between the Fas promoter polymorphism at position -670 and the known risk factor of LOAD, apolipoprotein E epsilon4, and no association was detected with disease progression. These findings show no evidence for an association between the Fas promoter polymorphism at position -670 and AD in our population. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739535     DOI: 10.1159/000076347

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  3 in total

1.  Fas antigen and sporadic Alzheimer's disease in Southern Italy: evaluation of two polymorphisms in the TNFRSF6 gene.

Authors:  Virginia Andreoli; Giuseppe Nicoletti; Nelide Romeo; Francesca Condino; Antonella La Russa; Maria Liguori; Ida Manna; Patrizia Spadafora; Aldo Quattrone; Rita Cittadella
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

2.  Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease.

Authors:  Mateus Rocha de Paula; Martín Gómez Ravetti; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

3.  The FAS gene, brain volume, and disease progression in Alzheimer's disease.

Authors:  Deniz Erten-Lyons; Anne Jacobson; Patricia Kramer; Andrew Grupe; Jeffrey Kaye
Journal:  Alzheimers Dement       Date:  2009-09-18       Impact factor: 21.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.